Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to unlock secrets of rare cholesterol diseases

NCT ID NCT05047354

First seen Sep 30, 2025 · Last updated Jun 20, 2026 · Updated 32 times

Summary

This natural history study observes people with Smith-Lemli-Opitz syndrome and related cholesterol disorders to better understand the diseases. Researchers will track symptoms, development, and lab results over several years. The goal is to find reliable measures that could be used in future treatment trials. No experimental treatment is given.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMITH-LEMLI-OPITZ SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could identify ways to measure disease progression, helping design future treatments for these rare cholesterol disorders.

What could go wrong

This is an observational study, not a treatment trial. It will not directly improve symptoms, and findings may not lead to effective therapies.

Conditions

The condition(s) this trial relates to.

CHILD syndrome desmosterolosis lathosterolosis Smith-Lemli-Opitz syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.